196 related articles for article (PubMed ID: 17117426)
1. Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications.
Kaufmann AM; Krise JP
J Pharm Sci; 2007 Apr; 96(4):729-46. PubMed ID: 17117426
[TBL] [Abstract][Full Text] [Related]
2. Lysosomal sequestration (trapping) of lipophilic amine (cationic amphiphilic) drugs in immortalized human hepatocytes (Fa2N-4 cells).
Kazmi F; Hensley T; Pope C; Funk RS; Loewen GJ; Buckley DB; Parkinson A
Drug Metab Dispos; 2013 Apr; 41(4):897-905. PubMed ID: 23378628
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the roles of autophagy and lysosomal trafficking defects in intracellular distribution-based drug-drug interactions involving lysosomes.
Logan R; Kong A; Krise JP
J Pharm Sci; 2013 Nov; 102(11):4173-80. PubMed ID: 23970383
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of amine accumulation in, and egress from, lysosomes.
Goldman SD; Funk RS; Rajewski RA; Krise JP
Bioanalysis; 2009 Nov; 1(8):1445-59. PubMed ID: 21083094
[TBL] [Abstract][Full Text] [Related]
5. Time-dependent effects of hydrophobic amine-containing drugs on lysosome structure and biogenesis in cultured human fibroblasts.
Logan R; Kong AC; Krise JP
J Pharm Sci; 2014 Oct; 103(10):3287-96. PubMed ID: 25042198
[TBL] [Abstract][Full Text] [Related]
6. Amine-containing molecules and the induction of an expanded lysosomal volume phenotype: a structure-activity relationship study.
Logan R; Kong AC; Axcell E; Krise JP
J Pharm Sci; 2014 May; 103(5):1572-80. PubMed ID: 24647827
[TBL] [Abstract][Full Text] [Related]
7. In Vitro and in Silico Tools To Assess Extent of Cellular Uptake and Lysosomal Sequestration of Respiratory Drugs in Human Alveolar Macrophages.
Ufuk A; Assmus F; Francis L; Plumb J; Damian V; Gertz M; Houston JB; Galetin A
Mol Pharm; 2017 Apr; 14(4):1033-1046. PubMed ID: 28252969
[TBL] [Abstract][Full Text] [Related]
8. Lysosomes as mediators of drug resistance in cancer.
Zhitomirsky B; Assaraf YG
Drug Resist Updat; 2016 Jan; 24():23-33. PubMed ID: 26830313
[TBL] [Abstract][Full Text] [Related]
9. Drug-drug interactions involving lysosomes: mechanisms and potential clinical implications.
Logan R; Funk RS; Axcell E; Krise JP
Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):943-58. PubMed ID: 22616667
[TBL] [Abstract][Full Text] [Related]
10. Lysosomal targeting strategies for design and delivery of bioactive for therapeutic interventions.
Sharma A; Vaghasiya K; Ray E; Verma RK
J Drug Target; 2018 Mar; 26(3):208-221. PubMed ID: 28862054
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic vacuolization during exposure to drugs and other substances.
Aki T; Nara A; Uemura K
Cell Biol Toxicol; 2012 Jun; 28(3):125-31. PubMed ID: 22431173
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of Lysosomal Trapping of Basic Lipophilic Compounds Using In Vitro Assays and In Silico Predictions Based on the Determination of the Full pH Profile of the Endo-/Lysosomal System in Rat Hepatocytes.
Schmitt MV; Lienau P; Fricker G; Reichel A
Drug Metab Dispos; 2019 Jan; 47(1):49-57. PubMed ID: 30409837
[TBL] [Abstract][Full Text] [Related]
13. A novel assay reveals that weakly basic model compounds concentrate in lysosomes to an extent greater than pH-partitioning theory would predict.
Duvvuri M; Krise JP
Mol Pharm; 2005; 2(6):440-8. PubMed ID: 16323951
[TBL] [Abstract][Full Text] [Related]
14. Targeting Lysosomes: A Strategy Against Chemoresistance in Cancer.
Shirbhate E; Singh V; Mishra A; Jahoriya V; Veerasamy R; Tiwari AK; Rajak H
Mini Rev Med Chem; 2024 Feb; ():. PubMed ID: 38343053
[TBL] [Abstract][Full Text] [Related]
15. Weak base permeability characteristics influence the intracellular sequestration site in the multidrug-resistant human leukemic cell line HL-60.
Duvvuri M; Gong Y; Chatterji D; Krise JP
J Biol Chem; 2004 Jul; 279(31):32367-72. PubMed ID: 15181006
[TBL] [Abstract][Full Text] [Related]
16. Role of phosphatidylserine binding in tissue distribution of amine-containing basic compounds.
Murakami T; Yumoto R
Expert Opin Drug Metab Toxicol; 2011 Mar; 7(3):353-64. PubMed ID: 21332386
[TBL] [Abstract][Full Text] [Related]
17. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
18. Lysosomotropic properties of weakly basic anticancer agents promote cancer cell selectivity in vitro.
Ndolo RA; Luan Y; Duan S; Forrest ML; Krise JP
PLoS One; 2012; 7(11):e49366. PubMed ID: 23145164
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of vacuolar H+-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drug-resistant renal epithelial cells.
Ouar Z; Bens M; Vignes C; Paulais M; Pringel C; Fleury J; Cluzeaud F; Lacave R; Vandewalle A
Biochem J; 2003 Feb; 370(Pt 1):185-93. PubMed ID: 12435274
[TBL] [Abstract][Full Text] [Related]
20. Identification of lysosomotropic compounds based on the distribution and size of lysosomes.
Seo I; Jha BK; Lim JG; Suh SI; Suh MH; Baek WK
Biochem Biophys Res Commun; 2014 Jul; 450(1):189-94. PubMed ID: 24878535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
